Back to search

France· FR:68011537

ACIDE ZOLEDRONIQUE MYLAN 4 mg/5 ml, solution à diluer pour perfusion

A medicinal product, registered in France by MYLAN PHARMACEUTICALS (IRLANDE), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedACIDE ZOLEDRONIQUE MYLAN 4 mg/5 ml, s…ATC—REGISTER NO.FR:68011537PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Manufacturer
MYLAN PHARMACEUTICALS (IRLANDE)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400926756017
    1 flacon(s) en verre
    EUR 115.53

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

ACIDE in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ACIDE products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Zoledronic Acid Koanaa, Zoledronsäure Fresenius Kabi
  • Belgium · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
  • Bulgaria · Золедронова Киселина Ейсфарма, Золедронова Киселина Ромфарм
  • Cyprus · Nordeloz, Zoledronic Acid Altan
  • Czechia · Zoledronic Acid Fresenius Kabi, Zomikos
  • Germany · Aszora, Clastizol
  • Denmark · Zoledo, Zoledronsyre Fresenius Kabi
  • Estonia · Zoledronic Acid Fresenius Kabi
  • Spain · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
  • Finland · Zobiore, Zoledronic Acid Fresenius Kabi
  • United Kingdom (Northern Ireland) · Zerlinda, Zoledronic Acid
  • Greece · Bonevin, Nordeloz
  • Croatia · Zolenat
  • Hungary · Osporil, Zoledronsav Fresenius Kabi
  • Ireland · Zerlinda, Zoledronic Acid
  • Iceland · Aclasta, Aszora
  • Italy · Acido Zoledronico Altan, Acido Zoledronico Fresenius Kabi
  • Liechtenstein · Aclasta, Zoledronic Acid Accord
  • Lithuania · Zoledronic Acid Fresenius Kabi
  • Luxembourg · Acide Zolédronique Fresenius Kabi, Zoledronate Eg
  • Latvia · Zoledronic Acid Fresenius Kabi
  • Netherlands · Zoledroninezuur Accord, Zoledroninezuur Cf
  • Norway · Aclasta, Zoledo
  • Poland · Osporil, Zerlinda
  • Portugal · Ácido Zoledrónico Accord, Ácido Zoledrónico Altan
  • Romania · Acid Zoledronic Accord, Acid Zoledronic Fresenius Kabi
  • Sweden · Zerlinda, Zoledronic Acid Accord
  • Slovenia · Zoledronska Kislina Accord, Zoledronska Kislina Fresenius Kabi
  • Slovakia · Kyselina, Kyselina Zoledrónová Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3ecfc555-7a8b-4aad-85ea-3ecac933064a
GET /v1/drugs/3ecfc555-7a8b-4aad-85ea-3ecac933064a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68011537",
  "date_amm": "2012-08-23",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/12/786",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about ACIDE.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.